Skip to main content

Paclitaxel Protein-Bound Injection Shortage

Last Updated: September 4, 2022
Status: Current

Reason for the Shortage
    • Apotex has paclitaxel protein-bound available.
    • TWi Pharmaceuticals has paclitaxel protein-bound available.
    • Bristol-Myers Squibb had Abraxane on shortage due to manufacturing delays.
Available Products
    • Abraxane intravenous lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, NDC 68817-0134-50
    • Paclitaxel protein-bound intravenous lyophilized powder for injection, Apotex, 100 mg, vial, NDC 60505-6230-04
    • Paclitaxel protein-bound intravenous lyophilized powder for injection, TWi Pharmaceuticals, 100 mg, vial, NDC 24979-0710-51

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated September 4, 2022 by Elyse MacDonald, PharmD, MS, BCPS. Created September 16, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer